Keywords: gilead, starts, clinical, trials, 2nd, cancer, drug

Gilead starts clinical trials of 2nd cancer drug

Article | 14 November 2001

Print This

Gilead Sciences has started a Phase I trial in Canada of GS7836, a newnucleoside analogue, in up to 40 patients with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in